Bachleda Mark (CIK 0001887762)

Latest company ownership

GRTX - Galera Therapeutics, Inc.

Role: Chief Commercial Officer

Shares held

11,000

Last filed at

Mar 20, 2023

Confidence Score

50.0

2025Q4

Confidence Score History

2023Q1 2025Q4

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Mar 16, 2023	Mar 20, 2023	Galera Therapeutics, Inc.	Chief Commercial Officer	Buy	91.3	+11,000	100.00%	✗	$24.7K